Learn Peptides So Fast it's UNREAL
A solo overview in which Dr. Ashley Froese sorts popular peptides into seven goal-based categories and says what each is researched for, closing with a plug for her course.
With Dr. Ashley Froese
Key moments
Tap a moment to play the video from there.
- 0:00Why a peptide frameworkFroese says there are over 60 popular peptides and that people need a system for thinking about them more than extra information.
- 0:34Biology of signalingShe explains that the body runs on signals and says stress, inflammation, poor sleep and aging degrade them, which is the gap she says peptides can fill.
- 1:25Inflammation and repair bucketShe covers GHK copper, KPV, thymosin alpha-1, BPC 157 and TB 500, describing the mechanism she associates with each.
- 4:53Fatigue and mitochondriaShe describes SS-31 as stabilizing the inner mitochondrial membrane and MOTS-c as a mitochondria-derived peptide that activates AMPK in preclinical studies.
- 6:48Growth hormone and recoveryShe discusses sermorelin, CJC-1295, ipamorelin, tesamorelin and IGF-LR3, and contrasts pulsatile release with direct IGF-1 delivery.
- 10:04Metabolism and fat lossShe describes semaglutide, tirzepatide and retatrutide as GLP-1 based agonists and AOD-9604 as a growth hormone fragment she calls a fat loss finisher.
- 12:32Focus and cognitionShe covers semax and its link to brain-derived neurotrophic factor, then dihexa and the safety concerns she raises about it.
- 14:13Stress and cortisolShe describes selank and semax as peptides reported to help bring over-amplified cortisol responses back toward baseline.
- 15:21Sleep and circadian rhythmShe covers epithalamin, pinealon and DSIP, tying them to the pineal gland, melatonin and deep sleep.
- 17:08Evidence limits and course pitchShe says much of the evidence is cellular or preclinical, urges understanding risks first, and promotes her Peptide Mastery course.
What the video says
Dr. Ashley Froese presents a single framework for thinking about peptides, which she says number over 60 popular ones. She starts with a short biology primer: the body runs on signals from the brain, hormones and cells, and she says stress, inflammation, poor sleep and aging degrade those signals. In her framing, peptides are signaling molecules that amplify biology rather than drugs.
She then goes through categories, naming specific peptides in each. For inflammation and tissue repair she covers GHK copper, KPV, thymosin alpha-1, BPC 157 and TB 500. For fatigue she covers SS-31 and MOTS-c. For recovery she covers sermorelin, CJC-1295, ipamorelin, tesamorelin and IGF-LR3. Metabolism and fat loss includes semaglutide, tirzepatide, retatrutide and AOD-9604. She adds cognition (semax, dihexa), stress (selank, semax) and sleep (epithalamin, pinealon, DSIP). For each she gives the mechanism she understands it to have, such as BPC 157 making tissues more responsive to repair signals or MOTS-c activating AMPK.
She repeatedly notes limits on the evidence. Much of what she cites for BPC 157 and MOTS-c comes from preclinical studies, and she says several compounds are not approved for human use. She says she cannot encourage using them, and she calls out real safety concerns with dihexa. She also points out which compounds she describes as approved for specific conditions, including SS-31, tesamorelin and semaglutide, and says retatrutide is expected to reach the market soon.
In the closing section she says a large share of peptide knowledge comes from cellular and preclinical research, with some learning from human use. She argues people should understand what a peptide could do and its risks before trying it. The last minutes promote her paid course, Peptide Mastery, and a supplement she links in the description.
On each compound
GHK-Cu1:35
Froese describes GHK copper as a naturally occurring peptide whose production she says falls with age. She says it has been researched for calming inflammatory gene expression and promoting collagen synthesis, and that it influences over 4,000 genes.
See how your DNA reads GHK-CuKPV2:02
She describes KPV as a small fragment of alpha-MSH studied for inflammation, especially in the gut, and says it turns off NF-kappaB. She notes the gut work is largely preclinical and that skin use is not necessarily researched.
See how your DNA reads KPVThymosin Alpha-13:06
Froese calls thymosin alpha-1 an immune-modulating peptide that, according to research, helps regulate rather than simply boost immunity. She says it is approved as a drug in over 35 countries for conditions like hepatitis.
See how your DNA reads Thymosin Alpha-1BPC-1573:30
She calls it probably the most well-known recovery peptide and says it appears to upregulate growth factor receptors. She says the tendon, ligament, muscle and gut research is all preclinical.
See how your DNA reads BPC-157TB-5004:08
Froese says TB 500 is a synthetic version of thymosin beta-4 that promotes cellular migration by upregulating actin. She frames it as recruiting repair crews, often paired with BPC 157.
See how your DNA reads TB-500SS-315:11
She describes SS-31 (elamipretide) as FDA approved for a specific mitochondrial disease and says research shows it binds cardiolipin to stabilize the inner mitochondrial membrane.
See how your DNA reads SS-31MOTS-c5:39
Froese says MOTS-c is encoded by mitochondrial DNA and, in preclinical studies, activates AMPK and increases glucose utilization. She says it is not FDA approved for human use and that she cannot encourage using it.
See how your DNA reads MOTS-cSermorelin7:09
She describes sermorelin as a growth hormone-releasing hormone analog that prompts the pituitary to release growth hormone in a natural pulsatile pattern, unlike synthetic human growth hormone.
See how your DNA reads SermorelinCJC-12957:40
Froese says CJC-1295 works like sermorelin on growth hormone-releasing hormone receptors but stays in the body longer, making it more potent. She notes it is often combined with ipamorelin.
See how your DNA reads CJC-1295Ipamorelin7:55
She says ipamorelin is a growth hormone releasing peptide that raises growth hormone without significantly increasing cortisol and prolactin, unlike hexarelin, GHRP-2 and GHRP-6.
See how your DNA reads IpamorelinTesamorelin8:11
Froese says tesamorelin is FDA approved for reducing visceral fat in HIV-associated lipodystrophy. She cites studies showing a 15 to 20% reduction in visceral fat over 6 to 12 months.
See how your DNA reads TesamorelinIGF-1 LR38:43
She describes IGF-LR3 as a longer-acting synthetic version of IGF-1 that biohackers use to bypass the pituitary. She calls it powerful, says users need to understand what they are doing, and says she cannot encourage it.
See how your DNA reads IGF-1 LR3Semaglutide10:14
Froese describes semaglutide as a GLP-1 receptor agonist developed for type 2 diabetes and now indicated for obesity. She says benefits extend to cardiovascular and inflammatory markers, with early research on neuroprotective effects.
See how your DNA reads SemaglutideTirzepatide10:46
She describes tirzepatide as a dual GLP-1 and GIP agonist. She says studies showed a 30% reduction in fatty liver and unprecedented weight loss in clinical trials.
See how your DNA reads TirzepatideRetatrutide11:16
Froese calls retatrutide a triple agonist (GLP-1, GIP and glucagon) and cites studies showing up to an 80% reduction in fatty liver. She says it is about to reach the market and that people are already obtaining it.
See how your DNA reads RetatrutideAOD-960411:48
She describes AOD-9604 as the fat-mobilizing fragment of growth hormone that does not affect blood sugar or growth. She says it did not work well for people needing to lose 50 to 100 lbs and is more of a finisher.
See how your DNA reads AOD-9604Semax12:50
Froese says semax was developed in Russia and acts mainly by increasing brain-derived neurotrophic factor. She says it has been shown to improve focus, clarity and alertness, can be taken nasally, and has brought cortisol back to baseline after stressful events.
See how your DNA reads SemaxDihexa13:21
She describes dihexa as an oral peptide acting on the hepatocyte growth factor and c-Met pathway, reported in preclinical research as up to 10 million times more potent than brain-derived neurotrophic factor. She stresses real safety concerns and says not to rush out to buy it.
See how your DNA reads DihexaSelank14:24
Froese says selank, also developed in Russia, has anxiolytic properties similar to Xanax and Ativan without sedation or addictive potential. She says it appears to modulate GABA and serotonin metabolism and to help regulate overactive cortisol.
See how your DNA reads SelankEpithalon15:35
She discusses epithalamin, studied for its effects on the pineal gland and melatonin production, and says it has been shown to activate telomerase. She places it at the intersection of sleep and longevity research.
See how your DNA reads EpithalonDSIP16:30
Froese says DSIP has been studied for promoting delta wave sleep, the deepest stage. She says it appears to help increase time spent in deep sleep.
See how your DNA reads DSIP“They're not necessarily drugs, they're signaling molecules, amplifiers of biology.”
“Don't rush out to buy it is all I'm saying.”
What this video doesn’t settle
- Much of the evidence she cites is cellular or preclinical, and the video gives no study names, so the human relevance of many claims is not established.
- She mentions that several compounds are not approved for human use and that people use them anyway, but the video gives no dosing, sourcing or safety data for them.
- The video ends with promotion of her paid course and a linked supplement, so the framing is partly commercial, and it does not compare her claims with independent sources.
Questions this video answers
What categories of peptides does Dr. Ashley Froese describe?
She groups peptides into inflammation and tissue repair, fatigue and mitochondria, recovery and growth hormone, metabolism and fat loss, cognition, stress and anxiety, and sleep. She says she cut sections on immunity and longevity for time.
What does Froese say about BPC 157 and TB 500 together?
She says BPC 157 appears to make tissues more receptive to repair signals, while TB 500 promotes cellular migration so repair signals reach the injury site. She notes they are often paired in what she calls the Wolverine blend, and that the BPC 157 evidence is all preclinical.
Which peptides does Froese describe as FDA approved?
She says SS-31 is approved for a specific mitochondrial disease, tesamorelin for visceral fat in HIV-associated lipodystrophy, and semaglutide for type 2 diabetes and obesity. She says retatrutide is about to reach the market.
What safety concerns does Froese raise about peptides?
She singles out dihexa for real safety concerns tied to the hepatocyte growth factor and c-Met pathway. More generally she says much of the evidence is cellular or preclinical and that people should understand risks before trying any peptide.
What does Froese say about peptides for sleep?
She names epithalamin, pinealon and DSIP. She says they are studied for melatonin and circadian rhythm effects, or for increasing time in deep sleep, which she links to growth hormone release and recovery.
Video by This Is Not Covered - Dr. Ashley Froese on YouTube, embedded as published. The summary is written by PeptidesDNA from the video; every claim in it is the speaker’s. Not affiliated with or endorsed by the creator. Not medical advice.
